Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists

Clinical and Experimental Nephrology

Volumn 13, Issue 5, 2009, Pages 405-414

  Wada, Jun ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Clinical trials; Diabetic nephropathy; History; Molecular mechanisms

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CHRONOLOGY; CLINICAL RESEARCH; DIABETIC NEPHROPATHY; ELECTRON MICROSCOPY; GLOMERULONEPHRITIS; HUMAN; JAPANESE; KIDNEY FAILURE; MICROALBUMINURIA; PREVALENCE; REVIEW; SCIENTIST; ULTRAFILTRATION;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HISTORY OF MEDICINE; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; INFLAMMATION; JAPAN; KIDNEY FAILURE, CHRONIC; POLYMERS; PROTEIN KINASE C; RESEARCH PERSONNEL;

EID: 70349664143     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0175-5     Document Type: Review

References (89)

1. E Imai M Horio K Iseki K Yamagata T Watanabe S Hara N Ura Y Kiyohara H Hirakata T Moriyama Y Ando K Nitta D Inaguma I Narita H Iso K Wakai Y Yasuda Y Tsukamoto S Ito H Makino A Hishida S Matsuo 2007 Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient Clin Exp Nephrol 11 2 156 163 17593516 10.1007/s10157-007-0463-x (Pubitemid 47012510)
2. E Imai M Horio K Nitta K Yamagata K Iseki S Hara N Ura Y Kiyohara H Hirakata T Watanabe T Moriyama Y Ando D Inaguma I Narita H Iso K Wakai Y Yasuda Y Tsukamoto S Ito H Makino A Hishida S Matsuo 2007 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease Clin Exp Nephrol 11 1 41 50 17384997 10.1007/s10157-006- 0453-4 (Pubitemid 46474965)
3. AY Wu NC Kong FA de Leon CY Pan TY Tai VT Yeung SJ Yoo A Rouillon MR Weir 2005 An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) study Diabetologia 48 1 17 26 15616801 10.1007/s00125-004-1599-9 1:STN:280:DC%2BD2M%2Fjt1yhsw%3D%3D (Pubitemid 40174652)
4. HH Parving JB Lewis M Ravid G Remuzzi LG Hunsicker 2006 Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective Kidney Int 69 11 2057 2063 16612330 10.1038/sj.ki.5000377 (Pubitemid 43924271)
5. F Henschen 1969 On the term diabetes in the works of Aretaeus and Galen Med Hist 13 2 190 192 4890048 1:STN:280:DyaF1M7osFajsQ%3D%3D
6. FP Schena 1994 Domenico Cotugno and his interest in proteinuria Am J Nephrol 14 4-6 325 329 7847464 10.1159/000168743 1:STN:280:DyaK2M7ltVWhsg%3D%3D
7. R Bright 1836 Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine Guy's Hosp Rep 1 336
8. NG De Santo MG Lamendola 1994 Luciano Armanni Am J Nephrol 14 4-6 448 451 7847484 10.1159/000168763
9. P Kimmelstiel C Wilson 1936 Intercapillary lesions in the glomeruli of the kidney Am J Pathol 12 83 97
10. R Murakami 1936 Beitrag zum Kennttniss der Veranderung des Nierenkorperchens beim diabetes mellitus Trans Soc Path Jpn 26 657
11. O Spuhler HU Zollinger 1943 Die diabetische glomerulosklerose Deutsch Arch Klin Med 190 321
12. DD Gellman CL Pirani JF Soothill RC Muehrcke RM Kark 1959 Diabetic nephropathy: a clinical and pathologic study based on renal biopsies Medicine (Baltimore) 38 321 367 1:STN:280:DyaF3c7kslOiuw%3D%3D
13. DD Gellman CL Pirani JF Soothill RC Muehrcke W Maduros RM Kark 1959 Structure and function in diabetic nephropathy; the importance of diffuse glomerulosclerosis Diabetes 8 4 251 256 13663708 1:STN:280: DyaG1M%2FptlCgsA%3D%3D
14. R Østerby HJ Gundersen 1975 Glomerular size and structure in diabetes mellitus. I. Early abnormalities Diabetologia 11 3 225 229 1149955 10.1007/BF00422326
15. CE Mogensen CK Christensen E Vittinghus 1983 The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy Diabetes 32 Suppl 2 64 78 6400670
16. Y Nakamoto E Takazakura H Hayakawa K Kawai K Dohi M Fujioka H Kida N Hattori J Takeuchi 1980 Intrarenal microaneurysms in diabetic nephropathy Lab Invest 42 4 433 439 7374108 1:STN:280:DyaL3c7osF2ruw%3D%3D
17. Y Saito H Kida S Takeda M Yoshimura H Yokoyama Y Koshino N Hattori 1988 Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions Kidney Int 34 3 389 396 3172647 10.1038/ki.1988.193 1:STN:280: DyaL1M%2Fht1Omtg%3D%3D
18. G Yajima 1976 A histopathological study on diabetic nephropathy-light and electron microscopic observations Acta Pathol Jpn 26 1 47 62 1274577 1:STN:280:DyaE283gt1CisQ%3D%3D
19. S Nishi M Ueno S Hisaki N Iino S Iguchi Y Oyama N Imai M Arakawa F Gejyo 2000 Ultrastructural characteristics of diabetic nephropathy Med Electron Microsc 33 2 65 73 11810461 10.1007/s007950070004 1:STN:280: DC%2BD38%2FoslynsQ%3D%3D (Pubitemid 32164780)
20. H Hayashi R Karasawa H Inn T Saitou M Ueno S Nishi Y Suzuki S Ogino Y Maruyama Y Kouda, et al. 1992 An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus Kidney Int 41 4 749 757 1513097 10.1038/ki.1992.117 1:STN:280:DyaK38zot1WgsQ%3D%3D
21. Y Suzuki M Ueno H Hayashi S Nishi H Satou R Karasawa H Inn S Suzuki Y Maruyama M Arakawa 1994 A light microscopic study of glomerulosclerosis in Japanese patients with noninsulin-dependent diabetes mellitus: the relationship between clinical and histological features Clin Nephrol 42 3 155 162 7994933 1:STN:280:DyaK2M%2Foslanuw%3D%3D
22. Z Ota K Shikata K Ota 1994 Nephrotic tunnels in glomerular basement membrane as revealed by a new electron microscopic method J Am Soc Nephrol 4 12 1965 1973 7919150 1:STN:280:DyaK2M%2Fgt1Oisg%3D%3D
23. K Hironaka H Makino Y Yamasaki Z Ota 1993 Renal basement membranes by ultrahigh resolution scanning electron microscopy Kidney Int 43 2 334 345 8441229 10.1038/ki.1993.51 1:STN:280:DyaK3s7otVeksg%3D%3D
24. H Makino Y Yamasaki T Haramoto K Shikata K Hironaka Z Ota YS Kanwar 1993 Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy Lab Invest 68 1 45 55 8423676 1:STN:280:DyaK3s7ktVejsw%3D%3D
25. T Moriya S Ohno K Nakazawa H Shigematsu Y Yajima 1993 Ultrastructural study of glomerular basement membrane in diabetic rats by quick-freezing and deep-etching method Virchows Arch B Cell Pathol Incl Mol Pathol 64 2 107 114 8220818 10.1007/BF02915102 1:STN:280:DyaK2c%2FjsFOntA%3D%3D (Pubitemid 23246556)
26. T Moriya S Ohno K Tanaka Y Fujita 2006 Clinical applications of the quick-freezing and deep-etching method to human diabetic nephropathy J Electron Microsc (Tokyo) 55 2 69 73 10.1093/jmicro/dfl010 1:CAS:528:DC%2BD28XosVagtL4%3D (Pubitemid 44290275)
27. D Suzuki M Miyazaki K Jinde T Koji M Yagame M Endoh Y Nomoto H Sakai 1997 In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy Kidney Int 52 1 111 119 9211353 10.1038/ki.1997.310 1:STN:280:DyaK2szlsFWmug%3D%3D
28. D Suzuki M Miyazaki R Naka T Koji M Yagame K Jinde M Endoh Y Nomoto H Sakai 1995 In situ hybridization of interleukin 6 in diabetic nephropathy Diabetes 44 10 1233 1238 7556963 10.2337/diabetes.44.10.1233 1:CAS:528:DyaK2MXotlGgsr0%3D
29. M Toyoda D Suzuki M Honma G Uehara T Sakai T Umezono H Sakai 2004 High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy Kidney Int 66 3 1107 1114 15327405 10.1111/j.1523-1755. 2004.00798.x 1:CAS:528:DC%2BD2cXnvVCrtLY%3D (Pubitemid 39121016)
30. R Kikkawa K Umemura M Haneda T Arimura K Ebata Y Shigeta 1987 Evidence for existence of polyol pathway in cultured rat mesangial cells Diabetes 36 2 240 243 3100369 10.2337/diabetes.36.2.240 1:CAS:528:DyaL2sXpvFyqug%3D%3D
31. M Haneda S Araki M Togawa T Sugimoto M Isono R Kikkawa 1997 Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions Diabetes 46 5 847 853 9133554 10.2337/diabetes.46.5.847 1:CAS:528: DyaK2sXjtVGntb8%3D (Pubitemid 27188263)
32. D Koya M Haneda H Nakagawa K Isshiki H Sato S Maeda T Sugimoto H Yasuda A Kashiwagi DK Ways GL King R Kikkawa 2000 Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J 14 3 439 447 10698958 1:CAS:528:DC%2BD3cXisFyht7g%3D
33. K Isshiki M Haneda D Koya S Maeda T Sugimoto R Kikkawa 2000 Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats Diabetes 49 6 1022 1032 10866056 10.2337/diabetes.49.6.1022 1:CAS:528:DC%2BD3cXjvFylu7s%3D
34. T Ishida M Haneda S Maeda D Koya R Kikkawa 1999 Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase Diabetes 48 3 595 602 10078562 10.2337/diabetes.48.3.595 1:CAS:528:DyaK1MXhsFymt78%3D
35. Z Makita S Radoff EJ Rayfield Z Yang E Skolnik V Delaney EA Friedman A Cerami H Vlassara 1991 Advanced glycosylation end products in patients with diabetic nephropathy N Engl J Med 325 12 836 842 1875967 1:STN:280: DyaK3Mzkt1OisQ%3D%3D
36. H Makino K Shikata K Hironaka M Kushiro Y Yamasaki H Sugimoto Z Ota N Araki S Horiuchi 1995 Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy Kidney Int 48 2 517 526 7564121 10.1038/ki.1995.322 1:STN:280:DyaK28%2FkslOhtQ%3D%3D
37. K Horie T Miyata K Maeda S Miyata S Sugiyama H Sakai C de Strihou VM Monnier JL Witztum K Kurokawa 1997 Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy J Clin Invest 100 12 2995 3004 9399945 10.1172/JCI119853 1:CAS:528:DyaK2sXotVyku7k%3D
38. Z Makita R Bucala EJ Rayfield EA Friedman AM Kaufman SM Korbet RH Barth JA Winston H Fuh KR Manogue, et al. 1994 Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure Lancet 343 8912 1519 1522 7911868 10.1016/S0140-6736(94)92935-1 1:STN:280:DyaK2c3ns1KktA%3D%3D (Pubitemid 24180047)
39. T Mitsuhashi H Nakayama T Itoh S Kuwajima S Aoki T Atsumi T Koike 1993 Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat Diabetes 42 6 826 832 8495806 10.2337/diabetes.42.6. 826 1:CAS:528:DyaK3sXltFakurg%3D (Pubitemid 23151574)
40. S Yamagishi Y Inagaki T Okamoto S Amano K Koga M Takeuchi Z Makita 2002 Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells J Biol Chem 277 23 20309 20315 11912219 10.1074/jbc.M202634200 1:CAS:528:DC%2BD38XkslWgtrs%3D (Pubitemid 34967325)
41. Y Yamamoto I Kato T Doi H Yonekura S Ohashi M Takeuchi T Watanabe S Yamagishi S Sakurai S Takasawa H Okamoto H Yamamoto 2001 Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice J Clin Invest 108 2 261 268 11457879 1:CAS:528:DC%2BD3MXlt1Kltrw%3D
42. N Uesugi N Sakata S Horiuchi R Nagai M Takeya J Meng T Saito S Takebayashi 2001 Glycoxidation-modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy Am J Kidney Dis 38 5 1016 1025 11684555 10.1053/ajkd.2001.28591 1:CAS:528: DC%2BD3MXovVGnsro%3D
43. K Fukuhara-Takaki M Sakai Y Sakamoto M Takeya S Horiuchi 2005 Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes J Biol Chem 280 5 3355 3364 15556945 10.1074/jbc.M408715200 1:CAS:528:DC%2BD2MXovVGjtg%3D%3D (Pubitemid 40223798)
44. M Iwano A Kubo T Nishino H Sato H Nishioka Y Akai H Kurioka Y Fujii M Kanauchi H Shiiki K Dohi 1996 Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus Kidney Int 49 4 1120 1126 8691733 10.1038/ki.1996.162 1:STN:280:DyaK283lsFWmtg%3D%3D
45. Y Isaka Y Fujiwara N Ueda Y Kaneda T Kamada E Imai 1993 Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney J Clin Invest 92 6 2597 2601 8254017 10.1172/JCI116874 1:CAS:528:DyaK2cXnsVOktA%3D%3D
46. Y Isaka Y Akagi Y Ando M Tsujie T Sudo N Ohno WA Border NA Noble Y Kaneda M Hori E Imai 1999 Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis Kidney Int 55 2 465 475 9987071 10.1046/j.1523-1755.1999. 00275.x 1:CAS:528:DyaK1MXht1Ghurw%3D (Pubitemid 29082873)
47. M Haneda R Kikkawa D Koya T Uzu S Maeda M Togawa Y Shigeta 1993 Alteration of mesangial response to ANP and angiotensin II by glucose Kidney Int 44 3 518 526 8231024 10.1038/ki.1993.276 1:CAS:528:DyaK2cXht1KjsL8%3D
48. M Haneda R Kikkawa S Maeda M Togawa D Koya N Horide N Kajiwara Y Shigeta 1991 Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation Kidney Int 40 2 188 194 1719265 10.1038/ki.1991.199 1:CAS:528:DyaK3MXlvF2mtbY%3D
49. R Kikkawa M Haneda K Sakamoto D Koya T Shikano S Nakanishi Y Matsuda Y Shigeta 1993 Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats Biochem Biophys Res Commun 193 2 700 705 8390251 10.1006/bbrc.1993.1681 1:CAS:528:DyaK3sXlslert78%3D
50. H Makino M Mukoyama K Mori T Suganami M Kasahara K Yahata T Nagae H Yokoi K Sawai Y Ogawa S Suga Y Yoshimasa A Sugawara I Tanaka K Nakao 2006 Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice Diabetologia 49 10 2514 2524 16917760 10.1007/s00125-006- 0352-y 1:CAS:528:DC%2BD28XptF2kur0%3D (Pubitemid 44359114)
51. H Sugimoto K Shikata M Matsuda M Kushiro Y Hayashi K Hiragushi J Wada H Makino 1998 Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy Diabetologia 41 12 1426 1434 9867209 10.1007/s001250051088 1:CAS:528:DyaK1cXnvVaiurg%3D (Pubitemid 28551613)
52. K Hiragushi J Wada J Eguchi T Matsuoka A Yasuhara I Hashimoto T Yamashita K Hida Y Nakamura K Shikata N Minamino K Kangawa H Makino 2004 The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats Kidney Int 65 2 540 550 14717924 10.1111/j.1523-1755.2004.00407.x 1:CAS:528:DC%2BD2cXhsVSnsb0%3D (Pubitemid 38130648)
53. Y Yamamoto Y Maeshima H Kitayama S Kitamura Y Takazawa H Sugiyama Y Yamasaki H Makino 2004 Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy Diabetes 53 7 1831 1840 15220208 10.2337/diabetes.53.7.1831 1:CAS:528:DC%2BD2cXlslWgtLY%3D (Pubitemid 38857042)
54. K Ichinose Y Maeshima Y Yamamoto H Kitayama Y Takazawa K Hirokoshi H Sugiyama Y Yamasaki K Eguchi H Makino 2005 Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model Diabetes 54 10 2891 2903 16186390 10.2337/diabetes.54.10.2891 1:CAS:528:DC%2BD2MXhtV2rs77F (Pubitemid 41401084)
55. K Ichinose Y Maeshima Y Yamamoto M Kinomura K Hirokoshi H Kitayama Y Takazawa H Sugiyama Y Yamasaki N Agata H Makino 2006 2-(8-hydroxy-6-methoxy-1- oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice Diabetes 55 5 1232 1242 16644677 10.2337/db05-1367 1:CAS:528:DC%2BD28XksFahtrc%3D
56. T Furuta T Saito T Ootaka J Soma K Obara K Abe K Yoshinaga 1993 The role of macrophages in diabetic glomerulosclerosis Am J Kidney Dis 21 5 480 485 8488815 1:STN:280:DyaK3s3ls1Sntw%3D%3D
57. H Sugimoto K Shikata K Hirata K Akiyama M Matsuda M Kushiro Y Shikata N Miyatake M Miyasaka H Makino 1997 Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation Diabetes 46 12 2075 2081 9392499 10.2337/diabetes.46.12.2075 1:CAS:528:DyaK2sXnslGqtLc%3D
58. S Okada K Shikata M Matsuda D Ogawa H Usui Y Kido R Nagase J Wada Y Shikata H Makino 2003 Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes Diabetes 52 10 2586 2593 14514644 10.2337/diabetes.52.10.2586 1:CAS:528:DC%2BD3sXotVWhsb0%3D (Pubitemid 37210549)
59. HK Usui K Shikata M Sasaki S Okada M Matsuda Y Shikata D Ogawa Y Kido R Nagase K Yozai S Ohga A Tone J Wada M Takeya S Horiuchi T Kodama H Makino 2007 Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation Diabetes 56 2 363 372 17259380 10.2337/db06-0359 1:CAS:528:DC%2BD2sXhs1ajsLw%3D (Pubitemid 46263074)
60. H Usui K Shikata M Matsuda S Okada D Ogawa T Yamashita K Hida M Satoh J Wada H Makino 2003 HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats Nephrol Dial Transplant 18 2 265 272 12543879 10.1093/ndt/18.2.265 1:CAS:528:DC%2BD3sXisVClsrs%3D (Pubitemid 36181675)
61. S Ohga K Shikata K Yozai S Okada D Ogawa H Usui J Wada Y Shikata H Makino 2007 Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-{kappa}B activation Am J Physiol Renal Physiol 292 4 F1141 F1150 17190910 10.1152/ajprenal.00288.2005 1:CAS:528:DC%2BD2sXks1KitbY%3D (Pubitemid 46578056)
62. K Yozai K Shikata M Sasaki A Tone S Ohga H Usui S Okada J Wada R Nagase D Ogawa Y Shikata H Makino 2005 Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions J Am Soc Nephrol 16 11 3326 3338 16177002 10.1681/ASN.2004111011 1:CAS:528:DC%2BD2MXht1Cnsr3O (Pubitemid 46179336)
63. A Tone K Shikata M Sasaki S Ohga K Yozai S Nishishita H Usui R Nagase D Ogawa S Okada Y Shikata J Wada H Makino 2005 Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats Diabetologia 48 11 2402 2411 16231067 10.1007/s00125-005-1945-6 1:CAS:528:DC%2BD2MXht1Skt7jM (Pubitemid 41618933)
64. T Miyata M Nangaku D Suzuki R Inagi K Uragami H Sakai K Okubo K Kurokawa 1998 A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy J Clin Invest 102 4 828 836 9710452 10.1172/JCI2450 1:CAS:528:DyaK1cXlsFaqs7s%3D
65. R Inagi Y Yamamoto M Nangaku N Usuda H Okamato K Kurokawa C van Ypersele de Strihou H Yamamoto T Miyata 2006 A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice Diabetes 55 2 356 366 16443768 10.2337/diabetes.55.02. 06.db05-0702 1:CAS:528:DC%2BD28XhsFajsrc%3D (Pubitemid 43343264)
66. J Wada YS Kanwar 1998 Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney Proc Natl Acad Sci USA 95 1 144 149 9419343 10.1073/pnas.95.1.144 1:CAS:528:DyaK1cXjtlyqsg%3D%3D (Pubitemid 28103921)
67. Q Yang B Dixit J Wada Y Tian EI Wallner SK Srivastva YS Kanwar 2000 Identification of a renal-specific oxido-reductase in newborn diabetic mice Proc Natl Acad Sci USA 97 18 9896 9901 10944187 10.1073/pnas.160266197 1:CAS:528:DC%2BD3cXmtlehsr4%3D
68. T Matsuoka J Wada I Hashimoto Y Zhang J Eguchi N Ogawa K Shikata YS Kanwar H Makino 2005 Gene delivery of Tim44 reduces mitochondrial superoxide production and ameliorates neointimal proliferation of injured carotid artery in diabetic rats Diabetes 54 10 2882 2890 16186389 10.2337/diabetes.54.10.2882 1:CAS:528:DC%2BD2MXhtV2rs77E (Pubitemid 41401083)
69. Y Zhang J Wada I Hashimoto J Eguchi A Yasuhara YS Kanwar K Shikata H Makino 2006 Therapeutic approach for diabetic nephropathy using gene delivery of translocase of inner mitochondrial membrane 44 by reducing mitochondrial superoxide production J Am Soc Nephrol 17 4 1090 1101 16510762 10.1681/ASN.2005111148 1:CAS:528:DC%2BD28XjvFSqtro%3D
70. T Okada J Wada K Hida J Eguchi I Hashimoto M Baba A Yasuhara K Shikata H Makino 2006 Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms Diabetes 55 6 1666 1677 16731829 10.2337/db05-1285 1:CAS:528:DC%2BD28XlsF2rtbc%3D (Pubitemid 44324119)
71. K Nagai H Arai M Yanagita T Matsubara H Kanamori T Nakano N Iehara A Fukatsu T Kita T Doi 2003 Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy J Biol Chem 278 20 18229 18234 12644472 10.1074/jbc.M213266200 1:CAS:528: DC%2BD3sXjs1Khs70%3D (Pubitemid 36799440)
72. K Nagai T Matsubara A Mima E Sumi H Kanamori N Iehara A Fukatsu M Yanagita T Nakano Y Ishimoto T Kita T Doi H Arai 2005 Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy Kidney Int 68 2 552 561 16014032 10.1111/j.1523-1755.2005.00433.x 1:CAS:528:DC%2BD2MXpt1WmsLg%3D (Pubitemid 43323110)
73. M Yanagita 2004 Gas6, warfarin, and kidney diseases Clin Exp Nephrol 8 4 304 309 15619028 10.1007/s10157-004-0305-z 1:CAS:528:DC%2BD2MXnvFShsA%3D%3D (Pubitemid 40941105)
74. M Yanagita 2004 The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology Curr Opin Nephrol Hypertens 13 4 465 470 15199298 10.1097/01.mnh.0000133981.63053.e9 1:CAS:528:DC%2BD2cXmsVKqtrY%3D (Pubitemid 38901627)
75. T Suganami M Mukoyama K Mori H Yokoi M Koshikawa K Sawai S Hidaka K Ebihara T Tanaka A Sugawara H Kawachi C Vinson Y Ogawa K Nakao 2005 Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy FASEB J 19 1 127 129 15496495 1:CAS:528:DC%2BD2MXitVGhtw%3D%3D
76. A Shimazaki Y Kawamura A Kanazawa A Sekine S Saito T Tsunoda D Koya T Babazono Y Tanaka M Matsuda K Kawai T Iiizumi M Imanishi T Shinosaki T Yanagimoto M Ikeda S Omachi A Kashiwagi K Kaku Y Iwamoto R Kawamori R Kikkawa M Nakajima Y Nakamura S Maeda 2005 Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy Diabetes 54 4 1171 1178 15793258 10.2337/diabetes.54.4.1171 1:CAS:528:DC%2BD2MXjtFWntbY%3D (Pubitemid 40446333)
77. N Tanaka T Babazono S Saito A Sekine T Tsunoda M Haneda Y Tanaka T Fujioka K Kaku R Kawamori R Kikkawa Y Iwamoto Y Nakamura S Maeda 2003 Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms Diabetes 52 11 2848 2853 14578305 10.2337/diabetes.52.11.2848 1:CAS:528:DC%2BD3sXovVagtLc%3D (Pubitemid 37339716)
78. Y Hayashi H Makino Z Ota 1992 Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes Diabet Med 9 4 366 370 1600709 10.1111/j.1464-5491.1992.tb01798.x 1:STN:280: DyaK383ovFWqug%3D%3D
79. H Okonogi M Nishimura Y Utsunomiya K Hamaguchi H Tsuchida Y Miura S Suzuki T Kawamura T Hosoya K Yamada 2001 Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus Clin Nephrol 55 5 357 364 11393380 1:STN:280:DC%2BD3MzhslOitg%3D%3D
80. Y Tomino S Suzuki C Azushima I Shou T Iijima M Yagame LN Wang HC Chen KN Lai SY Tan MJ Kim 2001 Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy J Clin Lab Anal 15 4 188 192 11436201 10.1002/jcla.1026 1:CAS:528:DC%2BD3MXlslaqt7c%3D (Pubitemid 32642739)
81. R Yoshikawa J Wada K Seiki T Matsuoka S Miyamoto K Takahashi S Ota K Taniai K Hida M Yamakado K Shikata Y Uehara Y Urade H Makino 2007 Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients Diabetes Res Clin Pract 76 3 358 367 17007955 10.1016/j.diabres.2006.09.004 1:CAS:528:DC%2BD2sXjslShtLk%3D (Pubitemid 46482712)
82. T Nakamura T Sugaya Y Kawagoe Y Ueda S Osada H Koide 2005 Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy Diabetes Care 28 11 2728 2732 16249547 10.2337/diacare.28.11.2728 1:CAS:528:DC%2BD2MXht1amt7rE (Pubitemid 43951167)
83. T Nakamura T Sugaya H Koide 2007 Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure Diabetologia 50 2 490 492 17171364 10.1007/s00125-006-0545-4 1:STN:280:DC%2BD2s%2FhvFegug%3D%3D
84. K Suzuki T Babazono H Murata Y Iwamoto 2005 Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy Diabetes Care 28 8 2038 2039 16043754 10.2337/diacare.28.8.2038 (Pubitemid 41060984)
85. Y Taguma Y Kitamoto G Futaki H Ueda H Monma M Ishizaki H Takahashi H Sekino Y Sasaki 1985 Effect of captopril on heavy proteinuria in azotemic diabetics N Engl J Med 313 26 1617 1620 3906398 1:STN:280:DyaL28%2FmsFemtA%3D%3D
86. Y Ohkubo H Kishikawa E Araki T Miyata S Isami S Motoyoshi Y Kojima N Furuyoshi M Shichiri 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res Clin Pract 28 2 103 117 7587918 10.1016/0168-8227(95)01064-K 1:CAS:528:DyaK2MXpsVWgtrs%3D
87. H Makino M Haneda T Babazono T Moriya S Ito Y Iwamoto R Kawamori M Takeuchi S Katayama 2007 Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes Diabetes Care 30 6 1577 1578 17389334 10.2337/dc06-1998 1:CAS:528:DC%2BD2sXntlWkt7g%3D (Pubitemid 46871174)
88. T Uzu M Sawaguchi H Maegawa A Kashiwagi 2007 Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART) Diabetes Care 30 6 1581 1583 17363751 10.2337/dc06-2493 (Pubitemid 46871176)
89. SI Araki M Haneda D Koya H Hidaka T Sugimoto M Isono K Isshiki M Chin-Kanasaki T Uzu A Kashiwagi 2007 Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes mellitus Diabetes 56 6 1727 1730 17360976 10.2337/db06-1646 1:CAS:528:DC%2BD2sXmtlKhsL0%3D (Pubitemid 46842621)